Jennifer E. Layden

9.7k citations

51 papers · 4.9k indexed · 3 hit papers · h-index 19

Impact in

Pharmacy top 0.5%
- Obesity and Health Practices
Physiology top 1%
- Smoking Behavior and Cessation
- Diet and metabolism studies

Papers in

Hepatology 17
- Hepatitis C virus research 15
Epidemiology 26
- Hepatitis B Virus Studies 13
- Liver Disease Diagnosis and Treatment 10
- Pneumocystis jirovecii pneumonia detection and treatment 3

Co-authors: David S. Ludwig Robert N. Butler Ronald C. Hershow Jacob A. Brody Leonard Hayflick David B. Allison S. Jay Olshansky Bruce A. Carnes
Journals: MMWR Morbidity and Mortality Weekly Report (7 papers)Open Forum Infectious Diseases (3 papers)New England Journal of Medicine (3 papers)Journal of Viral Hepatitis (3 papers)Transplantation (3 papers)
Partner nations: United States Ghana Nigeria

In The Last Decade

Jennifer E. Layden

50 papers receiving 4.6k citations

Hit Papers

align trajectories log scale

Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Final Report 2019 · 587 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 New England Journal of Medicine
2005 Obstetrical & Gynecological Survey
2005 New England Journal of Medicine

Peers

Countries citing papers authored by Jennifer E. Layden

Since Specialization

Citations

This map shows the geographic impact of Jennifer E. Layden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer E. Layden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer E. Layden more than expected).

Fields of papers citing papers by Jennifer E. Layden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer E. Layden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer E. Layden. The network helps show where Jennifer E. Layden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jennifer E. Layden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jennifer E. Layden Line = papers co-authored together Jennifer E. Layden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Plugging Public Health Data into the Health IT Ecosystem to Protect National Health NEJM Catalyst ·Jennifer E. Layden, Abdallah M.M. Badr, Niall Brennan, Micky Tripathi	2024	1
2	A Standard-Based Citywide Health Information Exchange for Public Health in Response to COVID-19: Development Study JMIR Public Health and Surveillance ·Bala Hota, Can Yahya Boztuğ, Anne F McIntyre, Olga Nestore, Jonathan Butement, 賢人左近, Omar Lateef, Jennifer E. Layden	2022	1
3	Opioid Prescribing Patterns Before Fatal Opioid Overdose American Journal of Preventive Medicine ·Ali B. Abbasi, Elizabeth Salisbury‐Afshar, K. Schadauel, Jennifer E. Layden, Mai T. Pho	2020	20
4	Characteristics of Persons Who Report Using Only Nicotine-Containing Products Among Interviewed Patients with E-cigarette, or Vaping, Product Use–Associated Lung Injury — Illinois, August–December 2019 MMWR Morbidity and Mortality Weekly Report ·Isaac Ghinai, Livia Navon, Jayleen K. L. Gunn, Lindsey M. Duca, Indrastuti Normahayu, Hyosoon Kang, Kawatsu Shizuka, Geroncio Fajardo, Jona Johnson, Lori Saathoff-Huber, Brian A. King, Christopher M. Jones, Vikram Krishnasamy, Jennifer E. Layden	2020	35
5	The Public Health Response to a Large Poisoning Outbreak Involving an Illicit Substance: Synthetic Cannabinoids Contaminated With a Long-Acting Anticoagulant Rodenticide, Illinois, March-July, 2018 Journal of Public Health Management and Practice ·Livia Navon, Erin D. Moritz, Connie Austin, Michael Wahl, Steven E. Aks, Jennifer E. Layden	2019	7
6	Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago Vaccine ·K. U. Smith, Alexander Gutfraind, Basmattee Boodram, Jennifer E. Layden, Jonathan Ozik, Kimberly Page, Scott J. Cotler, Marian Major, Harel Dahari	2019	9
7	Increased risk of PTLD in lung transplant recipients with cystic fibrosis Journal of Cystic Fibrosis ·Erin M. Lowery, William Adams, Shellee A. Grim, Nina M. Clark, Leah B. Edwards, Jennifer E. Layden	2017	14
8	A Synthesis of Hepatitis C prevalence estimates in Sub-Saharan Africa: 2000–2013 BMC Infectious Diseases ·Prativa Tiwari, William Adams, Stephanie Kliethermes‌, Lara R. Dugas, Neelam Balasubramanian, Jasmin Sandhu, H. Nde, Christina Small, Elizabeth A. Diekroger, Steven Scaglione, Jennifer E. Layden	2016	35
9	Next-Generation Sequencing Reveals Frequent Opportunities for Exposure to Hepatitis C Virus in Ghana PLoS ONE ·Joseph C. Forbi, Jennifer E. Layden, Richard Odame Phillips, Prativa Tiwari, Guoliang Xia, David S. Campo, Michael A. Purdy, Zoya Dimitrova, Dorcas Owusu, Lili Punkova, Pavel Skums, Shirley Owusu‐Ofori, Fred Stephen Sarfo, Gilberto Vaughan, Ya-ru GUO, Ohene Opare‐Sem, Richard Cooper, Yury Khudyakov	2015	7
10	Azithromycin use and outcomes in severe sepsis patients with and without pneumonia Journal of Critical Care ·Majid Afshar, Y. Kumagait, Jennifer E. Layden, Ellen L. Burnham	2015	17
11	Comparison of Patients from Nigeria and the USA Highlights Modifiable Risk Factors for Sickle Cell Anemia Complications Hemoglobin ·Titilola S. Akingbola, Bamidele O. Tayo, Babatunde Salako, Jennifer E. Layden, Lewis L. Hsu, Richard Cooper, Victor R. Gordeuk, Santosh L. Saraf	2014	23
12	Vitamin D levels are low in adult patients with sickle cell disease in Jamaica and West Africa PubMed ·Bamidele O. Tayo, Titilola S. Akingbola, Babatunde Lawal Salako, AC Wagner, Marvin Reid, Jennifer E. Layden, Ifeyinwa Osunkwo, Jacob Plange‐Rhule, Amy Luke, Ramón Durazo-Arvizú, Richard Cooper	2014	7
13	Association of Genetic Variants With Rapid Fibrosis Transplantation ·Jennifer E. Layden, Bamidele O. Tayo, Scott J. Cotler, Nina M. Clark, B. M. Krishnaswamy, Scott L. Friedman, Richard Cooper	2014	6
14	High Frequency of Active HCV Infection Among Seropositive Cases in West Africa and Evidence for Multiple Transmission Pathways Clinical Infectious Diseases ·Jennifer E. Layden, Richard Odame Phillips, Shirley Owusu‐Ofori, Fred Stephen Sarfo, Stephanie Kliethermes‌, Prativa Tiwari, Dorcas Owusu, Kenrad E. Nelson, Ohene Opare‐Sem, Lara R. Dugas, Amy Luke, David A. Shoham, Joseph C. Forbi, Yury Khudyakov, Richard Cooper	2014	16
15	Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid Diagnostic Microbiology and Infectious Disease ·H. Franke, Shellee A. Grim, William M. Janda, Jennifer E. Layden, Todd A. Lee, Nina M. Clark	2012	14
16	Impact of Donor and Recipient Race on Survival After Hepatitis C-Related Liver Transplantation Transplantation ·Jennifer E. Layden, Scott J. Cotler, Shellee A. Grim, Michael J. Fischer, Michael R. Lucey, Nina M. Clark	2012	9
17	Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes Journal of Antimicrobial Chemotherapy ·Shellee A. Grim, Karen Berger, Christine B. Teng, Seema Gupta, Jennifer E. Layden, William M. Janda, Nina M. Clark	2011	91
18	A Potential Decline in Life Expectancy in the United States in the 21st Century New England Journal of Medicine ·S. Jay Olshansky, (unknown), Ronald C. Hershow, Jennifer E. Layden, (unknown), Jacob A. Brody, Leonard Hayflick, Robert N. Butler, David B. Allison, David S. Ludwig Hit paper breakdown →	2005	1740
19	Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis C Journal of Viral Hepatitis ·Thomas J. Layden, Jennifer E. Layden, K. Rajender Reddy, Iván Ortega Rodríguez, Jennifer J. Poulakos, Avidan U. Neumann	2002	37
20	First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline Journal of Viral Hepatitis ·Jennifer E. Layden, Thomas J. Layden, K. Rajender Reddy, Iván Ortega Rodríguez, Jennifer J. Poulakos, Avidan U. Neumann	2002	63

About Jennifer E. Layden

Jennifer E. Layden is a scholar working on Hepatology, Epidemiology, Toxicology, Emergency Medicine and Infectious Diseases, having authored 51 papers that have together received 4.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (13 papers), Liver Disease Diagnosis and Treatment (10 papers), Smoking Behavior and Cessation (5 papers), Cannabis and Cannabinoid Research (5 papers), Poisoning and overdose treatments (4 papers), Alcohol Consumption and Health Effects (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Pharmacy (462 citations), Physiology (1.5k citations), Public Health, Environmental and Occupational Health (1.5k citations), Health (381 citations) and Aging (69 citations). Jennifer E. Layden has collaborated with scholars based in United States, Ghana and Nigeria. Frequent co-authors include David S. Ludwig, Robert N. Butler, Ronald C. Hershow, Jacob A. Brody, Leonard Hayflick, David B. Allison, S. Jay Olshansky, Bruce A. Carnes, Douglas J. Passaro and Isaac Ghinai. Their work appears in journals such as MMWR Morbidity and Mortality Weekly Report, Open Forum Infectious Diseases, New England Journal of Medicine, Journal of Viral Hepatitis and Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact